MDxHealth (MDXH) Q4 2024 Earnings
MDXH·Reported May 14, 2025·After market close
MDxHealth reported Q4 2024 revenue of $48.1M (+24.0% YoY), beat analyst consensus of $25.2M by $22.9M. Diluted EPS came in at $-0.19 (+38.7% YoY), missed the $-0.13 consensus by $0.06.
Revenue
$48.1Mbeat by $22.9M
Consensus: $25.2MDiluted EPS
$-0.19missed by $0.06
Consensus: $-0.13
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q4 2024 Earnings FAQ
Common questions about MDxHealth's Q4 2024 earnings report.
MDxHealth (MDXH) reported Q4 2024 earnings on May 14, 2025 after market close.
MDxHealth reported revenue of $48.1M and diluted EPS of $-0.19 for Q4 2024.
Revenue beat the consensus estimate of $25.2M by $22.9M. EPS missed the consensus estimate of $-0.13 by $0.06.
Compared to the same quarter a year prior, revenue grew 24.0% from $38.7M a year earlier and diluted EPS grew 38.7% from $-0.31.